A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine whether a single overnight, eight-hour
administration of a 7% NaCl solution delivered by the Parion Sciences transnasal Pulmonary
Aerosol Delivery (tPAD) device has a significant effect on mucociliary clearance in subjects
with cystic fibrosis, as compared to no treatment. This study will be conducted at the
University of Pittsburgh Medical Center.